# New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of a New Animal Drug Application; Change of Sponsor
> **Food and Drug Administration** · Final rule; technical amendments. · Published 2022-02-28 · Effective 2022-02-28 · 87 FR 10964
## Document
- **Document number:** 2022-03538
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 87 FR 10964
- **CFR reference:** 21 CFR 500
- **Publication date:** 2022-02-28
- **Effective date:** 2022-02-28
- **HHS docket:** Docket No. FDA-2021-N-0002
## Abstract

The Food and Drug Administration (FDA or we) is amending the animal drug regulations to reflect application-related actions for new animal drug applications (NADAs), abbreviated new animal drug applications (ANADAs), and a conditionally approved new animal drug application (cNADA) during July, August, and September 2021. FDA is informing the public of the availability of summaries of the basis of approval and of environmental review documents, where applicable. The animal drug regulations are also being amended to improve the accuracy of the regulations.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2022/02/28/2022-03538/new-animal-drugs-approval-of-new-animal-drug-applications-withdrawal-of-approval-of-a-new-animal)
---
*AI Analytics · CC0 1.0*